Subsets of adult cancers also overexpress IGF2, including 20% of hepatocarcinoma [7], 40% of colon carcinoma, 90% of liposarcoma [8], and also adrenocortical carcinoma [9]. This evidence concerns the gene IGF2 and cancer.